| 000 | 01736 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515171557.0 | ||
| 264 | 0 | _c20090909 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1744-6872 | ||
| 024 | 7 |
_a10.1097/FPC.0b013e32832c484b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVeitch, Zachary W | |
| 245 | 0 | 0 |
_aInduction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance. _h[electronic resource] |
| 260 |
_bPharmacogenetics and genomics _cJun 2009 |
||
| 300 |
_a477-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3-Hydroxysteroid Dehydrogenases _xgenetics |
| 650 | 0 | 4 | _aAldo-Keto Reductase Family 1 Member C3 |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aEnzyme Inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyprostaglandin Dehydrogenases _xgenetics |
| 650 | 0 | 4 |
_aHydroxysteroid Dehydrogenases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 700 | 1 | _aGuo, Baoqing | |
| 700 | 1 | _aHembruff, Stacey L | |
| 700 | 1 | _aBewick, Adam J | |
| 700 | 1 | _aHeibein, Allan D | |
| 700 | 1 | _aEng, Jamei | |
| 700 | 1 | _aCull, Stephanie | |
| 700 | 1 | _aMaclean, David A | |
| 700 | 1 | _aParissenti, Amadeo M | |
| 773 | 0 |
_tPharmacogenetics and genomics _gvol. 19 _gno. 6 _gp. 477-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FPC.0b013e32832c484b _zAvailable from publisher's website |
| 999 |
_c18867682 _d18867682 |
||